Clinical Research Coordination Unit
Banī Suwayf, Egypt
NCT Number: NCT07269002
This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify potential medication issues and support therapeutic decision-making. The study was conducted in both adult and pediatric inpatients as part of routine clinical care. No investigational drugs or devices were used.
Looking for future studies?
Notify Me2 year and older
All sexes
Interventional
Not applicable
Banī Suwayf, Egypt
This study was conducted to assess the impact of a structured pharmacist-led medication-safety program implemented across inpatient units in a multispecialty hospital. The program incorporated routine clinical pharmacist review of inpatient medication therapy and the use of smartphone-based clinical decision-support applications to assist with identifying potential medication issues and supporting therapeutic optimization.
The intervention was applied prospectively in both adult and pediatric inpatients receiving pharmacologic treatment. All activities were performed as part of routine clinical service enhancement, without the use of investigational drugs or devices. The study focused on evaluating medication-safety indicators, clinical process measures, and patient-related outcomes before and after implementation of the pharmacist-led program.
The aim of the project was to enhance medication accuracy, reduce preventable medication-related problems, and support evidence-based decision-making in a real-world hospital environment. This description summarizes the overall service-improvement approach without disclosing study-specific operational details.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adult and pediatric inpatients
Patients receiving at least one scheduled medication dose during admission
Exclusion criteria
Patients admitted for procedures with no medication administration
Patients discharged before assessment could be performed
A structured clinical pharmacist program that includes inpatient medication review, identification of potential medication-related problems, and use of smartphone-based clinical decision-support applications to support therapeutic decision-making and enhance medication safety practices.
Time frame: From hospital admission through study completion (an average of 5 days)
Time frame: From hospital admission through study completion (an average of 5 days)
A composite measure assessing medication-safety performance in inpatient settings, including identification of medication discrepancies, potential medication risks, and pharmacist-detected issues during routine clinical care. The measure reflects overall improvement in medication-safety processes following the implementation of the pharmacist-led program.
Beni-Suef University
Other
"Role of Clinical Pharmacy and Mobile Medical Applications in Detection and Minimization of Different Medication Errors in Hospitalized Patients From Adults and Children".
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06731387
Interdepartmental Communication, Medication Safety
Sint-Niklaas, Oost-Vlaanderen, Belgium
View Trial DetailsNCT07584005
Medication Safety, Nursing Education
Samsun, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06644105
Drug Metabolism, Drug Safety
Chengdu, China
View Trial DetailsNCT04990986
Medication Safety, Patient Safety
Aalborg, Denmark
View Trial Details